Advanced Search

 

Study ID Status Title Patient Level Data
100650 Completed Clinical Evaluation of GW685698 for Perennial Allergic Rhinitis- Dose-Finding Study by Double-Blind Comparative Method -
100690 Completed A randomised, double blind triple dummy, placebo controlled balanced incomplete block crossover study to evaluate the change in response to a 7% CO2 challenge and pharmacokinetics of single oral doses of GW597599 and paroxetine (5 or 7.5 mg) either alone or in combination, or alprazolam (0.75 mg) in healthy volunteers Study Listed on ClinicalStudyDataRequest.com
100716 Completed An open label repeat dose study to investigate the effect of GW597599 (15 mg) and paroxetine (10 mg) given in combination for 15 days on the pharmacokinetics of midazolam and dextromethorphan in healthy male and female volunteers Study Listed on ClinicalStudyDataRequest.com
100723 Completed A 24 Week Randomized, Double-blind, Double-dummy, Multicenter Study to Compare the Efficacy of Formulation X and AVANDIA™ (8mg OD) in Subjects with Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
100732 Completed A Phase IIIB, Randomized, Open-Label, Multicenter Study of the Safety and Efficacy of GW433908 (700mg BID) plus ritonavir (100mg BID) Versus Lopinavir/ritonavir (400mg/100mg BID) when Administered in Combination with the Abacavir/Lamivudine (600mg/300mg) Fixed-Dose Combination Tablet QD in Antiretroviral-Naive HIV-1 Infected Adults Over 48 Weeks
100732_144weeks Completed A Phase IIIB, Randomized, Open-Label, Multicenter Study of the Safety and Efficacy of GW433908 (700mg BID) plus ritonavir (100mg BID) Versus Lopinavir/ritonavir (400mg/100mg BID) when Administered in Combination with the Abacavir/Lamivudine (600mg/300mg) Fixed-Dose Combination Tablet QD in Antiretro
100789 Completed A two-part, dose-rising study to evaluate the safety, tolerability and pharmacokinetics of single intravenous doses of GW679769 when administered alone and in combination with intravenous or oral doses of dexamethasone in healthy adult subjects Study Listed on ClinicalStudyDataRequest.com
100807 Completed Randomised, open label, two period, crossover study to compare the steroid systemic exposure of Fluticasone Propionate (FP) from FP/Salmeterol (SALM) (500/50) DISKUS and Budesonide (BUD) from BUD/formoterol (FOR).(200/6) Turbuhaler in patients with severe Chronic Obstructive Pulmonary Disease. Study Listed on ClinicalStudyDataRequest.com
100901 Terminated An open label extension study to evaluate safety and efficacy of mepolizumab in patients with hypereosinophilic syndromes Study Listed on ClinicalStudyDataRequest.com
100917 Completed An open, multicentric, post-marketing surveillance study to assess the safety and reactogenicity of GlaxoSmithKline Biologicals' DTPa-IPV/Hib vaccine administered at 3, 4, 5 and 18 months of age, in healthy infants. Study Listed on ClinicalStudyDataRequest.com
101040 Completed A double-blind, randomized study to evaluate the immunogenicity and reactogenicity of two different lots of GlaxoSmithKline Biologicals' combined hepatitis A/hepatitis B vaccine in healthy children between 6 and 15 years of age. Study Listed on ClinicalStudyDataRequest.com
101093 Completed Pharmacogenetic Research on Hypersensitivity to Abacavir
101197 Completed An open, multicentric, phase IV clinical trial to assess the immunogenicity and reactogenicity of GlaxoSmithKline Biologicals’ combined diphtheria-tetanus-acellular pertussis vaccine (Infanrix™) administered to healthy infants at 2, 4 and 6 months of age. Study Listed on ClinicalStudyDataRequest.com
101222 Completed Study to demonstrate the non-inferiority of GSK Biologicals' DTPw-HBV/Hib Kft. vaccine compared to GSK Biologicals' Tritanrix™-HepB/Hiberix™ vaccine and to separate administration of DTPw-HBV Kft. and Hiberix™ vaccines with respect to the immunogenicity of all antigens, when administered to healthy infants. Study Listed on ClinicalStudyDataRequest.com
101223 Completed Study to assess the lot-to-lot consistency of the production method of GSK Biologicals' DTPw-HBV/ Hib Kft. vaccine and to compare to GSK Biologicals' Tritanrix™-HepB/Hiberix™ vaccine, when administered as a primary vaccination course. Study Listed on ClinicalStudyDataRequest.com
101377 Completed A phase III, open, randomized, multicentre study to demonstrate the non-inferiority of GSK Biologicals' combined hepatitis A and hepatitis B vaccine according to a 0-1-6 month schedule, to the monovalent hepatitis A vaccine Havrix and hepatitis B vaccine Engerix separately administered, in healthy adults Study Listed on ClinicalStudyDataRequest.com
101464 Completed A Multicenter, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of a Flexible Dose of Lamotrigine Compared to Placebo as an Adjunctive Therapy to an Atypical Antipsychotic Agent(s) in Subjects with Schizophrenia Study Listed on ClinicalStudyDataRequest.com
101468/001 Completed A single blind assessment of the safety and effects on serum prolactin and on cardiovascular function of oral administration of a range of doses (10µg to 2.5 mg) of a solution of SK&F101468 in healthy male volunteers.
101468/003 Completed A single blind placebo controlled rising dose study of the effects of oral SK&F101468 (250 µg to 1000µg) on supine and erect blood pressure and plasma catecholamines in healthy male volunteers.
101468/004 Completed Effect of chronic administration of carvedilol, 6.25mg to 25mg b.i.d., on renal hemodynamics in mild to moderate essential hypertension.
101468/005 Completed A double-blind, placebo-controlled, crossover study to assess the CNS effects of SK&F 101468 in normal volunteers using quantitative pharmaco-EEG and topographical coloured dynamic brain mapping techniques.
101468/009 Completed An open study to investigate the tolerance and preliminary pharmacokinetics of single intravenous doses of 100, 200, 400, 600 and 800 mg SK&F 101468 following domperidone pre-treatment (20 mg t.i.d.) in healthy male volunteers.
101468/010 Completed The effects of a single dose of 20 mg domperidone on the pharmacokinetic, safety and pharmacodynamic responses to a single dose of 800 mcg SK&F101468, in healthy volunteers.
101468/011 Completed A Study to Investigate the Pharmacokinetics and to Profile the Metabolites of 14C SK&F 101468 When Administered by the Intravenous and Oral Route to Healthy Male Subjects
101468/012 Completed A Study to Assess the Acute Effects of a Standard Meal on the Plasma Pharmacokinetics of SK&F 101468, After Administration of a Single Oral Dose of 800g SK&F 101468 in Normal Man

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.